Joshua A. Kazam - 12 Jan 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
12 Jan 2022
Net transactions value
+$189,000
Form type
4
Filing time
14 Jan 2022, 13:13:32 UTC
Previous filing
06 Jan 2022
Next filing
09 Mar 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Purchase $189,000 +15,000 +6.2% $12.60 258,885 12 Jan 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.